CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade ICU Medical - ICUI CFD

    91.23
    4.04%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.18
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    ICU Medical Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 87.69
    Open* 86.49
    1-Year Change* -45.66%
    Day's Range* 86.06 - 91.23
    52 wk Range 78.28-212.43
    Average Volume (10 days) 313.35K
    Average Volume (3 months) 4.78M
    Market Cap 2.00B
    P/E Ratio -100.00K
    Shares Outstanding 24.14M
    Revenue 2.25B
    EPS -1.17
    Dividend (Yield %) N/A
    Beta 0.62
    Next Earnings Date Feb 26, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 30, 2023 87.69 3.15 3.73% 84.54 90.24 84.42
    Nov 29, 2023 84.58 1.04 1.24% 83.54 87.38 83.54
    Nov 28, 2023 84.49 -1.64 -1.90% 86.13 87.93 84.28
    Nov 27, 2023 84.25 1.31 1.58% 82.94 85.60 82.94
    Nov 24, 2023 84.31 1.17 1.41% 83.14 85.12 83.14
    Nov 22, 2023 84.10 1.06 1.28% 83.04 84.33 82.88
    Nov 21, 2023 82.93 -2.01 -2.37% 84.94 85.58 82.75
    Nov 20, 2023 86.23 1.29 1.52% 84.94 86.58 84.64
    Nov 17, 2023 85.49 -1.20 -1.38% 86.69 87.58 84.97
    Nov 16, 2023 87.00 0.66 0.76% 86.34 88.68 85.80
    Nov 15, 2023 88.37 4.07 4.83% 84.30 90.46 84.30
    Nov 14, 2023 87.40 3.78 4.52% 83.62 88.35 83.61
    Nov 13, 2023 81.90 1.30 1.61% 80.60 83.06 80.05
    Nov 10, 2023 81.76 0.72 0.89% 81.04 82.40 78.24
    Nov 9, 2023 81.02 -4.18 -4.91% 85.20 86.94 80.13
    Nov 8, 2023 86.53 3.47 4.18% 83.06 86.95 80.69
    Nov 7, 2023 84.27 -15.50 -15.54% 99.77 99.77 83.07
    Nov 6, 2023 101.92 -0.60 -0.59% 102.52 103.23 99.76
    Nov 3, 2023 102.47 2.44 2.44% 100.03 103.91 99.99
    Nov 2, 2023 99.95 1.66 1.69% 98.29 101.23 98.29

    ICU Medical Events

    Time (UTC) Country Event
    Monday, February 26, 2024

    Time (UTC)

    21:00

    Country

    US

    Event

    Q4 2023 ICU Medical Inc Earnings Release
    Q4 2023 ICU Medical Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 2280 1316.31 1271 1266.21 1400.04
    Revenue 2280 1316.31 1271 1266.21 1400.04
    Cost of Revenue, Total 1582.24 824.818 809.507 794.344 830.012
    Gross Profit 697.761 491.49 461.497 471.864 570.028
    Total Operating Expense 2322.9 1193.06 1172.84 1158.85 1370.28
    Selling/General/Admin. Expenses, Total 607.633 301.935 283.57 276.982 320.002
    Research & Development 92.984 47.498 42.948 48.611 52.867
    Unusual Expense (Income) 71.421 18.164 27.434 86.311 147.003
    Operating Income -42.898 123.245 98.162 107.36 29.756
    Other, Net -1.232 0.699 2.785 1.096 -3.973
    Net Income Before Taxes -114.409 123.186 97.494 114.707 22.374
    Net Income After Taxes -74.286 103.135 86.87 101.035 29.619
    Net Income Before Extra. Items -74.286 103.135 86.87 101.035 29.619
    Net Income -74.286 103.135 86.87 101.035 28.793
    Income Available to Common Excl. Extra. Items -74.286 103.135 86.87 101.035 29.619
    Income Available to Common Incl. Extra. Items -74.286 103.135 86.87 101.035 28.793
    Diluted Net Income -74.286 103.135 86.87 101.035 28.793
    Diluted Weighted Average Shares 23.868 21.781 21.591 21.545 21.601
    Diluted EPS Excluding Extraordinary Items -3.11237 4.73509 4.02344 4.68949 1.37119
    Diluted Normalized EPS -1.0978 5.49863 5.08131 8.21808 5.79468
    Other Operating Expenses, Total -32.091 0 9 -47.4 20.4
    Interest Income (Expense), Net Non-Operating -67.725 0.942 -5.253 6.251 -3.409
    Total Extraordinary Items 0 -0.826
    Depreciation / Amortization 0.712 0.648 0.383
    Gain (Loss) on Sale of Assets -2.554 -1.7 1.8
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 549.31 568.649 578.014 597.857 561.004
    Revenue 549.31 568.649 578.014 597.857 561.004
    Cost of Revenue, Total 356.983 376.608 403.069 411.461 393.411
    Gross Profit 192.327 192.041 174.945 186.396 167.593
    Total Operating Expense 546.55 559.254 578.236 598.324 561.052
    Selling/General/Admin. Expenses, Total 150.641 152.347 142.737 153.276 158.578
    Research & Development 22.302 19.761 23.446 23.105 22.562
    Depreciation / Amortization 0.254 0.225 0.196 0.176 0.17
    Unusual Expense (Income) 12.354 11.013 9.626 14.365 13.525
    Other Operating Expenses, Total 4.016 -0.7 -0.838 -4.059 -27.194
    Operating Income 2.76 9.395 -0.222 -0.467 -0.048
    Interest Income (Expense), Net Non-Operating -24.622 -22.353 -21.287 -19.951 -18.173
    Gain (Loss) on Sale of Assets -0.229 -0.297 -0.254 -1.4 -0.6
    Other, Net -0.772 -0.134 0.316 0.511 1.967
    Net Income Before Taxes -22.863 -13.389 -21.447 -21.307 -16.854
    Net Income After Taxes -9.934 -9.812 -15.536 -13.208 -7.474
    Net Income Before Extra. Items -9.934 -9.812 -15.536 -13.208 -7.474
    Net Income -9.934 -9.812 -15.536 -13.208 -7.474
    Income Available to Common Excl. Extra. Items -9.934 -9.812 -15.536 -13.208 -7.474
    Income Available to Common Incl. Extra. Items -9.934 -9.812 -15.536 -13.208 -7.474
    Diluted Net Income -9.934 -9.812 -15.536 -13.208 -7.474
    Diluted Weighted Average Shares 24.075 24.014 23.988 23.908 23.897
    Diluted EPS Excluding Extraordinary Items -0.41263 -0.40859 -0.64766 -0.55245 -0.31276
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.0729 -0.10246 -0.37994 -0.12384 0.07144
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 1235.2 1029.81 920.777 882.197 927.036
    Cash and Short Term Investments 213.008 567.247 410.784 292.637 382.11
    Cash & Equivalents 208.784 552.827 396.097 268.67 344.781
    Short Term Investments 4.224 14.42 14.687 23.967 37.329
    Total Receivables, Net 225.265 110.05 127.769 222.361 212.855
    Accounts Receivable - Trade, Net 221.719 105.894 124.093 202.219 176.298
    Total Inventory 696.009 290.235 314.928 337.64 311.163
    Prepaid Expenses 56.537 40.659 50.622 16.862 15.142
    Other Current Assets, Total 44.377 21.618 16.674 12.697 5.766
    Total Assets 4515.64 1880.74 1763.69 1692.38 1585.39
    Property/Plant/Equipment, Total - Net 713.575 508.212 513.199 490.55 432.641
    Property/Plant/Equipment, Total - Gross 1240.02 944.951 889.667 810.705 694.864
    Accumulated Depreciation, Total -526.444 -436.739 -376.468 -320.155 -262.223
    Goodwill, Net 1449.26 43.439 33.001 31.245 11.195
    Intangibles, Net 982.766 188.311 197.231 211.408 133.421
    Other Long Term Assets, Total 131.152 106.347 86.509 76.982 79.073
    Total Current Liabilities 494.559 200.777 195.488 248.468 249.289
    Accounts Payable 215.902 81.128 71.864 128.629 120.469
    Accrued Expenses 211.115 104.906 90.901 111.348 125.006
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 2425.71 264.707 261.426 315.138 321.736
    Total Long Term Debt 1625.53 2.067 2.388 0 0
    Deferred Income Tax 126.007 1.49 1.663 2.091 0.721
    Other Liabilities, Total 179.617 60.373 61.887 64.579 71.726
    Total Equity 2089.93 1616.03 1502.27 1377.24 1263.66
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 2.399 2.128 2.106 2.074 2.049
    Additional Paid-In Capital 1331.25 721.412 693.068 668.947 657.899
    Retained Earnings (Accumulated Deficit) 837.501 911.787 808.652 721.782 620.747
    Treasury Stock - Common -0.243 -0.027 -0.039 -0.157 -0.095
    Other Equity, Total -121.757 -19.032 -4.306 -17.282 -16.945
    Total Liabilities & Shareholders’ Equity 4515.64 1880.74 1763.69 1692.38 1585.39
    Total Common Shares Outstanding 23.9934 21.2799 21.0578 20.7421 20.4916
    Long Term Investments 3.694 4.62 12.974 0 2.025
    Other Current Liabilities, Total 37.038 14.1 32.169 8.491 3.814
    Unrealized Gain (Loss) 40.779 -0.237 2.784 1.88
    Current Port. of LT Debt/Capital Leases 30.504 0.643 0.554
    Capital Lease Obligations 1.855 2.067 2.388
    Long Term Debt 1623.68
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 1219.41 1244.74 1213.03 1235.2 1199.36
    Cash and Short Term Investments 198.998 197.699 224.182 213.008 246.798
    Cash & Equivalents 197.192 195.887 220.947 208.784 243.879
    Short Term Investments 1.806 1.812 3.235 4.224 2.919
    Total Receivables, Net 164.187 164.843 142.489 225.265 215.791
    Accounts Receivable - Trade, Net 161.797 162.225 139.459 221.719 212.845
    Total Inventory 759.622 775.269 747.965 696.009 625.268
    Prepaid Expenses 42.361 48.025 53.126 56.537 86.918
    Other Current Assets, Total 54.24 58.906 45.263 44.377 24.589
    Total Assets 4376.86 4463.04 4470.63 4515.64 4450.48
    Property/Plant/Equipment, Total - Net 685.343 695.587 706.606 710.977 732.821
    Property/Plant/Equipment, Total - Gross 1282.56 1270.35 1257.04 1237.42 1230.92
    Accumulated Depreciation, Total -597.214 -574.767 -550.432 -526.444 -498.098
    Goodwill, Net 1444.46 1464.48 1462.73 1449.26 1369.72
    Intangibles, Net 891.28 929.83 957.682 982.766 1020.66
    Long Term Investments 3.145 3.161 3.166 0.516 1.831
    Other Long Term Assets, Total 133.232 125.246 127.427 136.928 126.086
    Total Current Liabilities 464.043 483.88 462.177 494.559 489.034
    Accounts Payable 149.288 167.054 186.42 215.902 205.042
    Accrued Expenses 221.659 225.843 203.273 211.115 212.42
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 46.585 41.354 35.966 30.504 25.075
    Other Current Liabilities, Total 46.511 49.629 36.518 37.038 46.497
    Total Liabilities 2278.51 2348.23 2370.23 2425.71 2437.67
    Total Long Term Debt 1591.26 1602.85 1614.14 1625.53 1631.54
    Capital Lease Obligations 2.018 2.134 1.939 1.855 1.692
    Deferred Income Tax 77.845 89.684 114.594 126.007 153.599
    Other Liabilities, Total 145.358 171.808 179.327 179.617 163.498
    Total Equity 2098.36 2114.82 2100.4 2089.93 2012.81
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 2.414 2.411 2.411 2.399 2.398
    Additional Paid-In Capital 1356.35 1345.06 1339.91 1331.25 1323.18
    Retained Earnings (Accumulated Deficit) 824.993 817.755 827.689 837.501 853.037
    Treasury Stock - Common -0.672 -1.611 -8.006 -0.243 -0.126
    Unrealized Gain (Loss) 42.135 40.476 35.202 40.779 48.394
    Other Equity, Total -126.862 -89.27 -96.805 -121.757 -214.076
    Total Liabilities & Shareholders’ Equity 4376.86 4463.04 4470.63 4515.64 4450.48
    Total Common Shares Outstanding 24.1394 24.104 24.0636 23.9934 23.9793
    Long Term Debt 1589.24 1600.72 1612.2 1623.68 1629.85
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -74.286 103.135 86.87 101.035 28.793
    Cash From Operating Activities -62.129 267.538 222.752 101.918 160.215
    Cash From Operating Activities 235.151 89.698 85.631 76.916 74.735
    Deferred Taxes -66.734 0.874 -18.037 4.68 -19.997
    Non-Cash Items 80.735 59.666 67.217 35.603 82.093
    Cash Taxes Paid 27.504 19.562 31.628 9.675 12.598
    Changes in Working Capital -236.995 14.165 1.071 -116.316 -5.409
    Cash From Investing Activities -1909.47 -90.687 -98.139 -166.888 -103.37
    Capital Expenditures -99.329 -81.169 -100.39 -106.04 -100.779
    Other Investing Cash Flow Items, Total -1810.14 -9.518 2.251 -60.848 -2.591
    Cash From Financing Activities 1637.03 -16.87 -0.04 -10.907 8.023
    Issuance (Retirement) of Stock, Net -2.098 1.037 0.317 -10.907 8.023
    Foreign Exchange Effects -9.478 -3.251 2.854 -0.234 -10.159
    Net Change in Cash -344.043 156.73 127.427 -76.111 54.709
    Cash Interest Paid 63.713 0.858 1.753 0.549 0.709
    Issuance (Retirement) of Debt, Net 1641.31 -0.607 -0.357 0 0
    Financing Cash Flow Items -2.177 -17.3
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -9.812 -74.286 -58.75 -45.542 -38.068
    Cash From Operating Activities 41.245 -62.129 -60.418 -62.727 -1.342
    Cash From Operating Activities 55.744 235.151 178.338 119.697 53.138
    Deferred Taxes -9.328 -66.734 -63.047 -45.798 -26.102
    Non-Cash Items 25.148 80.735 54.014 34.003 34.869
    Changes in Working Capital -20.507 -236.995 -170.973 -125.087 -25.179
    Cash From Investing Activities -15.183 -1909.47 -1885.47 -1872.94 -1867.75
    Capital Expenditures -16.737 -99.329 -75.275 -52.479 -25.993
    Other Investing Cash Flow Items, Total 1.554 -1810.14 -1810.19 -1820.46 -1841.76
    Cash From Financing Activities -15.837 1637.03 1647.42 1644.89 1648.92
    Issuance (Retirement) of Stock, Net -8.254 -2.098 -2.635 -7.446 -5.769
    Issuance (Retirement) of Debt, Net -7.583 1641.31 1651.9 1654.19 1656.54
    Foreign Exchange Effects 1.938 -9.478 -10.477 -6.347 -3.224
    Net Change in Cash 12.163 -344.043 -308.948 -297.129 -223.399
    Cash Taxes Paid
    Cash Interest Paid
    Financing Cash Flow Items 0 -2.177 -1.852 -1.852 -1.852
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Janus Henderson Investors Investment Advisor/Hedge Fund 10.5915 2556347 -4522 2023-06-30 LOW
    Smiths Group PLC Corporation 10.358 2500000 2500000 2022-01-06
    T. Rowe Price Investment Management, Inc. Investment Advisor 9.9039 2390397 -28967 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.8058 2125357 -4995 2023-06-30 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 8.2895 2000733 -205651 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 6.5705 1585848 -42917 2023-06-30 LOW
    Lopez (George A) Individual Investor 5.1793 1250063 2200 2023-03-21
    JP Morgan Asset Management Investment Advisor 2.7786 670638 -50346 2023-06-30 LOW
    Victory Capital Management Inc. Investment Advisor/Hedge Fund 2.6518 640039 42162 2023-06-30 LOW
    Fuller & Thaler Asset Management Inc. Investment Advisor/Hedge Fund 2.6412 637474 -32869 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.5244 609296 -5833 2023-06-30 LOW
    Fidelity Management & Research Company LLC Investment Advisor 2.3211 560212 407583 2023-06-30 LOW
    Neuberger Berman, LLC Investment Advisor/Hedge Fund 1.9206 463549 -4044 2023-06-30 LOW
    Segall Bryant & Hamill, LLC Investment Advisor/Hedge Fund 1.5443 372740 1743 2023-06-30 LOW
    Atlanta Capital Management Company, L.L.C. Investment Advisor 1.3405 323538 -14212 2023-06-30 LOW
    Schroder Investment Management North America Inc. Investment Advisor 1.326 320052 -10887 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.3111 316437 12951 2023-06-30 LOW
    Silvercrest Asset Management Group LLC Investment Advisor/Hedge Fund 1.3053 315056 15748 2023-06-30 LOW
    Boston Trust Walden Company Investment Advisor 1.1083 267494 15712 2023-09-30 LOW
    Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.0123 244339 -41469 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    ICU Medical Company profile

    About ICU Medical Inc

    ICU Medical, Inc. (ICU) is engaged in the development, manufacturing and sale of medical products used in infusion therapy and critical care applications. The Company’s product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. Its critical care products help clinicians get real-time access to patients’ hemodynamic and cardiac status with a portfolio of monitoring systems and advanced sensors and catheters. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. It sells its products through its direct sales force and through independent distributors. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, ICU Medical Inc revenues increased 4% to $1.32B. Net income increased 19% to $103.1M. Revenues reflect Infusion Consumables segment increase of 17% to $555.2M, Critical Care segment increase of 1% to $49.3M, United States segment increase of 3% to $941.8M, EMEA segment increase of 11% to $147.5M. Net income benefited from Restructuring Charges/Provisions decrease of 37% to $18M (expense).

    Equity composition

    Common Stock $.10 Par, 03/11, 80M auth., 14,855,000 issd., less 1,123,000 shs. in Treas @ $38.95M. Insiders & Strategic holders own 11.33%. IPO 3/92, 1.3M shares @ $11.00 by Sutro& Co., Inc. PO 7/95, 2.07M shares @ $12 by Rodman & Renshaw, Inc. 3/02, 4/93, 3-for-2 stock splits. FY'03 Q4 are being restated.

    Industry: Medical Equipment, Supplies & Distribution (NEC)

    951 Calle Amanecer
    SAN CLEMENTE
    CALIFORNIA 92673-6212
    US

    Income Statement

    • Annual
    • Quarterly

    News

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    People also watch

    US100

    16,001.20 Price
    +0.470% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Gold

    2,072.25 Price
    +1.760% 1D Chg, %
    Long position overnight fee -0.0193%
    Short position overnight fee 0.0111%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    Oil - Crude

    74.50 Price
    -1.560% 1D Chg, %
    Long position overnight fee -0.0136%
    Short position overnight fee -0.0083%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    XRP/USD

    0.62 Price
    +0.830% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading